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The dietary intake of certain fatty acids might contribute to the development of allergic diseases such as hay fever and asthma. We investigated the associ-
ation between the concentrations of fifteen fatty acids in serum phospholipids, as a marker of dietary intake and metabolism, and hay fever, allergic sen-
sitisation and total IgE in adults. Data from a population-based cross-sectional study on respiratory health, including the measurement of fatty acids in the
serum phospholipids of 740 adults between 20 and 64 years of age, were analysed. Positive associations were found between hay fever and arachidonic acid,
and allergic sensitisation and oleic acid. No other fatty acids showed any association with hay fever or allergic sensitisation. Elevated levels of total IgE were
not related to fatty acids. Concentrations of long-chain n-3 fatty acids, trans fatty acids or saturated fatty acids in serum phospholipids were not associated
with allergic diseases in adults in this study. The present result on the association between hay fever and arachidonic acid is consistent with current hypoth-
eses but warrants further research.
Allergic rhinitis: Sensitisation: Total IgE: Fatty acids: Phospholipids: European Community Respiratory Health Survey
The causes underlying the rising prevalence of allergic diseases
such as asthma and hay fever in developed countries over the
past three decades are still unknown. Because this increase in
allergic diseases has coincided with large changes in environmen-
tal factors like air pollution or nutrition, these factors may be
linked to its aetiology. In particular, the altered consumption of
long-chain PUFAs was suggested to be linked with the rising
prevalence of allergic diseases. Over the past few decades, the
consumption of the n-6 fatty acid linoleic acid (18 : 2n-6) and
of trans fatty acids rose, whereas the consumption of polyunsatu-
rated n-3 fatty acids and saturated fatty acids fell, in Western
countries (Sanders, 2000; Simopoulos, 2002).
Linoleic acid is a precursor of arachidonic acid, which can be
converted to the pro-inflammatory eicosanoids leukotriene B4
and prostaglandin E2. Prostaglandin E2 may shift the balance of
T-helper cells from type 1 to type 2 and may thus lead to an
enhanced production of immunoglobulin E (IgE) from B-cells
(Seaton et al. 1994; Black, 1999). In contrast, eicosanoids derived
from the n-3 fatty acid eicosapentaenoic acid (EPA) can down
regulate the production of prostaglandin E2 (Kankaanpää et al.
1999). It has been hypothesised that an increased consumption
of linoleic acid in the diet results in an enhanced production of
arachidonic acid-derived eicosanoids, while eicosanoids derived
from EPA are produced in smaller quantities (Black & Sharpe,
1997).
Trans fatty acids in human nutrition are derived from the indus-
trial process of the catalytic hydrogenation of vegetable oils for
food manufacturing and appear in dairy fat because of ruminant
activity (Larqué et al. 2001; Mozaffarian et al. 2004). In
Germany, 79 % of trans fatty acids in 1995 were derived from
natural animal sources (Hulshof et al. 1999), particularly butter
(49·6 %) and cheese (14·0 %). A possible link between trans
fatty acids and allergy is that they appear to impair the desatura-
tion of linoleic acid and a-linolenic acid to their long-chain
derivatives (Koletzko, 1992; Decsi & Koletzko, 1995).
The hypotheses on the influence of altered fatty acid consump-
tion on allergic diseases are an increase in the ratio of n-6 : n-3
fatty acids, the contribution of single fatty acids and an altered
fatty acid metabolism, for example a lack of D-6 fatty acid
desaturase.
No substantial association between the ratio of ingested n-6 and
n-3 fatty acids and hay fever or sensitisation was found in two
recently published studies (Nagel et al. 2003; Trak-Fellermeier
et al. 2004). In a previous paper using these data, we reported
no association between the n-6 : n-3 ratio in serum phospholipids
and hay fever or allergic sensitisation (Kompauer et al. 2004),
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which is consistent with an Australian study on asthma and atopy
(Woods et al. 2004). In this paper, we focus on the contribution of
single fatty acids to hay fever, allergic sensitisation and the con-
centration of total IgE in serum, and use the concentration of fatty




The present study is based on a sample from one of the two surveys
conducted in Erfurt, East Germany as part of the European Commu-
nity Respiratory Health Survey. This survey was conducted in adults
aged 20–64 years in 1991–92. The study design and population
sampling are described in detail elsewhere (Burney et al. 1994;
Nowak et al. 1996). In brief, a total of 1282 participants answered
the main questionnaire, and blood samples were drawn from 1258
participants for analysis of specific and total IgE. A serum sample
was also stored at 2808C for later analyses. Additionally, a subset
of the participants was asked to participate in a dietary survey, for
which they filled in 3 d weighted records on their diet (Trak-Feller-
meier et al. 2004). From this subset, unthawed serum samples were
still available for 740 participants (313 women and 427 men). For
the present study, these samples were used for the assessment of
fatty acids in their serum phospholipids.
Questionnaire data and blood tests
Participants who answered ‘Yes’ to the question ‘Do you have
nasal allergies, including hay fever?’ were categorised as partici-
pants who suffered from hay fever. Therefore subjects with both
seasonal and perennial allergic rhinitis were included as ‘hay
fever’ subjects as in other European Community Respiratory
Health Survey papers.
Allergic sensitisation to common aeroallergens (house dust
mite Dermatophagoides pteronyssinus, grass pollen, cat, Clados-
porium and birch pollen as a local allergen in northern Europe)
was assessed by specific serum IgE measurement, using the Phar-
macia CAP System (Pharmacia Diagnostics, Uppsala, Sweden).
Subjects with at least one specific IgE $ 0·7 kU/l was categorised
as sensitised. We did not analyse asthma as an outcome variable,
because only eighteen participants answered ‘Yes’ to the question
‘Have you ever had asthma?’
The Ethics Committee of the Medical School, Erfurt, East
Germany approved the study.
Analysis of fatty acids
Serum was kept frozen at 2808C until analysis in 2003 and was
never thawed before measurement of fatty acids. Serum lipids
were extracted with hexane–isopropanol (3:2 v/v). Phospholipids
were isolated by TLC: phospholipids, triglycerides, cholesterol
esters and nonesterified fatty acids were isolated by development
of the plates in n-heptane-diisopropylether-glacial acetic acid
(60:40:3, v/v/v) and fatty acid methyl esters were obtained by
acid-catalysed trans-esterification in methanol. Methyl esters were
extracted into hexane and frozen until analysis in a gas chromato-
graph: Hewlett Packard 5890 series II gas chromatograph (Hewlett
Packard, Waldbronn, Germany) (Kolarovic & Fournier, 1986). In
total, thirty-six fatty acids were measured, and the results were
expressed as percentages of the total fatty acids in serum
phospholipids.
Statistical analysis
From all thirty-six fatty acids analysed, we chose fifteen to assess
the association with hay fever and allergic sensitisation, and eight
to assess the association with total IgE in serum. We selected pal-
mitic and stearic acids as a marker of saturated fatty acids in
serum phospholipids. The monounsaturated fatty acids palmito-
leic acid, oleic acid and trans-18 : 1 (trans 9, trans 11 combined)
were chosen because they were associated with hay fever and
allergic sensitisation in other studies (Weiland et al. 1999;
Nagel et al. 2003; Trak-Fellermeier et al. 2004). Linoleic acid
and its desaturation and elongation products were chosen because
eicosanoids derived from the n-6 fatty acid arachidonic acid
might promote allergic diseases, whereas eicosanoids derived
from the n-3 fatty acid EPA might have a beneficial effect. All
fatty acid values were normally distributed except for EPA,
from which we extracted the square root to reach normal
distribution.
Differences in the prevalence of allergic sensitisation or hay
fever between women and men were assessed by the x 2 test.
The association between the concentration of certain fatty acids
in serum phospholipids and allergic sensitisation or hay fever
was assessed by using logistic regression models. Fatty acid
values were divided into quartiles. Odds ratios were adjusted
for sex, age group, BMI, education, smoking status and total
energy intake. Additionally, we conducted a sex-stratified analysis
for certain fatty acids as a sensitivity analysis.
Differences in total IgE in serum between the sexes were
assessed using the Wilcoxon test. Because IgE values differed sig-
nificantly between sexes, we applied only sex-stratified analyses.
Values of total IgE were strongly skewed to the right and were
therefore log-transformed to normalise the distribution. The
association between total IgE and fatty acids was expressed as
means ratios with 95 % CI. Means ratios were adjusted for age
group, BMI, education, smoking status and total energy intake.
We did not adjust for a family history of atopy because this
confounder showed no effect on the point estimates, and many
participants were not aware of the atopic status of their parents,
who were born long before 1950.
SAS version 8.2 (SAS Institute, Cary, NC, USA) was used for
all calculations.
Results
Table 1 shows the basic characteristics of the study population
included in this analysis. No statistically significant sex differ-
ences were observed in the prevalence of hay fever or allergic
sensitisation assessed as at least one specific IgE $ 0·7 kU/l.
Total IgE in serum differed significantly between the
sexes (P,0·0001) with a geometric mean of 28·7 (95 % CI
24·5, 33·5) kU/l in women and 50·8 (95 % CI 44·4, 58·1) kU/l
in men.
The largest proportion of fatty acids in the serum phospholipids
were saturated (43·9 %), followed by n-6 polyunsaturated
(34·5 %), monounsaturated (14·3 %) and n-3 polyunsaturated
(6·2 %) fatty acids (Table 2).
Concerning the concentrations of single fatty acids, palmitic
acid 16 : 0 formed the largest proportion, with 26·9 %, followed
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by linoleic acid 18 : 2n-6 (20·2 %), arachidonic acid 20 : 4n-6
(9·6 %) and oleic acid 18 : 1n-9 (9·5 %) as shown in Table 2.
Table 3 shows adjusted odds ratios and corresponding 95 % CI
for the association between the fifteen selected fatty acids in
serum phospholipids and hay fever in the total population. Ara-
chidonic acid showed the strongest association with hay fever.
Odds ratios were 3·85 (95 % CI 1·67, 8·88) for the second, 2·54
(95 % CI 1·05, 6·11) for the third and 3·27 (95 % CI 1·39, 7·69)
for the fourth quartile (Table 3). Similar associations were
found for both sexes when the data were analysed in a sex-
specific manner (unpublished results). We also observed a
tendency for a positive association between docosahexaenoic
acid and hay fever, but this was not significant.
Table 4 shows adjusted odds ratios and corresponding 95 % CI
for the association between the fifteen selected fatty acids in serum
phospholipids and allergic sensitisation in the total population.
Oleic acid was positively associated with allergic sensitisation,
but this was only significant in the third quartile with an odds
ratio 2·03 (95 % CI 1·20, 3·43).
No consistent association was observed between the other
measured fatty acids in serum phospholipids and allergic rhinitis
or sensitisation (Tables 3 and 4).
Table 2. Fatty acid composition (%) in serum phospholipids of 739 adults
Total (n 739) Women (n 312) Men (n 427)
Fatty acid Mean SD Mean SD Mean SD
Saturated
Palmitic acid (16 : 0) 26·86 1·72 27·33 1·64 26·52 1·70
Stearic acid (18 : 0) 13·42 1·36 13·05 1·48 13·70 1·20
Sum of saturated fatty acids* 43·88 1·63 43·82 1·04 43·93 1·95
Monounsaturated
Palmitoleic acid (16 : 1n-7) 0·53 0·23 0·50 0·19 0·55 0·25
Oleic acid (18 : 1n-9) 9·48 1·27 9·32 1·06 9·60 1·40
trans-18 : 1 0·36 0·15 0·36 0·14 0·35 0·16
Sum of monounsaturated fatty acids† 14·29 1·49 14·01 1·18 14·49 1·65
n-6 Series polyunsaturated
Linoleic acid (18 : 2n-6) 20·23 2·69 20·51 2·62 20·03 2·73
g-Linolenic acid (18 : 3n-6) 0·10 0·04 0·09 0·04 0·11 0·04
Dihomo-g-linolenic acid (20 : 3n-6) 2·87 0·59 2·93 2·86 2·82 2·76
Arachidonic acid (20 : 4n-6) 9·61 1·50 9·44 1·43 9·73 1·55
Adrenic acid (22 : 4n-6) 0·34 0·07 0·32 0·06 0·35 0·07
n-6-Docosapentaenoic acid (22 : 5n-6) 0·24 0·14 0·26 0·12 0·22 0·20
Sum of n-6 fatty acids‡ 34·47 2·35 34·66 2·06 34·33 2·54
n-3 Series polyunsaturated
a-Linolenic acid (18 : 3n-3) 0·18 0·06 0·19 0·06 0·18 0·06
Eicosapentaenoic acid (20 : 5n-3) 1·09 0·59 1·03 0·59 1·13 0·59
n-3-Docosapentaenoic acid (22 : 5n-3) 0·96 0·21 0·84 0·21 1·04 0·17
Docosahexaenoic acid (22 : 6n-3) 3·85 0·93 4·05 0·91 3·71 0·93
Sum of n-3 fatty acids§ 6·22 1·43 6·25 1·43 6·19 1·44
* Sum of saturated fatty acids 14 : 0 þ 16 : 0 þ 18 : 0 þ 20 : 0 þ 22 : 0 þ 24 : 0.
† Sum of monounsaturated fatty acids 16 : 1n-7 þ 18 : 1n-7 þ 18 : 1n-9 þ 20 : 1n-9 þ 22 : 1n-9 þ 24 : 1n-9.
‡ Sum of n-6 fatty acids (18 : 2n-6 þ 18 : 3n-6 þ 20 : 2n-6 þ 20 : 3n-6 þ 20 : 4n-6 þ 22 : 2n-6 þ 22 : 4n-6 þ 22 : 5n-6) divided by
total fatty acids.
§ Sum of n-3 fatty acids (18 : 3n-3 þ 18 : 4n-3 þ 20 : 3n-3 þ 20 : 5n-3 þ 22 : 5n-3 þ 22 : 6n-3) divided by total fatty acids.
Table 1. Characteristics of the study population
Total (n 739) Women (n 312) Men (n 427)
Mean SD Mean SD Mean SD
Hay fever* (%) 10·3 11·9 9·1
Allergic sensitisation† (%) 22·9 22·8 23·0
Age (years) 41·5 12·3 40·0 12·0 42·7 12·3
BMI 25·5 4·0 24·9 4·4 25·9 3·7
Energy intake (kcal/d) 2225 620 1837 436 2509 579
Smoking status (%)
Never smokers 40·2 52·6 31·2
Ex-smokers 27·7 19·5 33·7
Current smokers 32·1 27·9 35·1
Educational level (%)
High 46·0 44·0 47·4
Medium 32·4 34·1 31·2
Low 21·6 21·9 21·4
* Defined as answering ‘Yes’ to the question ‘Do you have nasal allergies, including hay fever?’
† Defined as at least one specific IgE $ 0·7 kU/l.
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Neither oleic acid (18 : 1n-9) nor linoleic acid (18 : 2n-6),
dihomo-g-linolenic acid (20 : 3n-6), arachidonic acid
(20 : 4n-6), docosatetraenoic acid (22 : 4n-6), a-linolenic acid
(18 : 3n-3), EPA (20 : 5n-3) or trans-18 : 1 showed any relation-




We found a positive association between arachidonic acid in
serum phospholipids and hay fever, but these results were not
reflected in the association between arachidonic acid and allergic
Table 3. Adjusted odds ratios and corresponding 95 % CI for the association between selected fatty acids in
serum phospholipids (%) and hay fever* (n 737)
Adjusted odds ratio (95 % CI)†
2nd quartile‡ 3rd quartile‡ 4th quartile‡
Fatty acid
Saturated
Palmitic acid (16 : 0) 0·84 (0·43–1·63) 0·63 (0·31–1·28) 0·60 (0·29–1·25)
Stearic acid (18 : 0) 1·23 (0·61–2·48) 0·96 (0·44–2·08) 1·48 (0·72–3·04)
Monounsaturated
Palmitoleic acid (16 : 1n-7) 0·80 (0·41–1·55) 0·75 (0·38–1·48) 0·78 (0·38–1·59)
Oleic acid (18 : 1n-9) 1·62 (0·85–3·10) 0·95 (0·47–1·91) 0·73 (0·33–1·60)
trans-18 : 1 0·89 (0·43–1·84) 1·56 (0·81–3·01) 0·77 (0·36–1·63)
n-6 Series polyunsaturated
Linoleic acid (18 : 2n-6) 0·64 (0·29–1·37) 0·91 (0·44–1·87) 1·33 (0·66–2·67)
g-Linolenic acid (18 : 3n-6) 1·24 (0·63–2·45) 0·94 (0·45–1·97) 1·41 (0·67–2·98)
Dihomo-g-linolenic acid (20 : 3n-6) 0·92 (0·45–1·86) 1·19 (0·60–2·34) 1·25 (0·61–2·55)
Arachidonic acid (20 : 4n-6) 3·85 (1·67–8·88) 2·54 (1·05–6·11) 3·27 (1·39–7·69)
Docosatetraenoic acid (22 : 4n-6) 1·01 (0·51–2·00) 1·00 (0·50–2·00) 1·04 (0·51–2·11)
n-6-Docosapentaenoic acid (22 : 5n-6) 1·57 (0·79–3·11) 1·09 (0·53–2·26) 0·99 (0·47–2·09)
n-3 Series polyunsaturated
a-Linolenic acid (18 : 3n-3) 0·86 (0·44–1·69) 1·07 (0·56–2·05) 0·60 (0·29–1·25)
Eicosapentaenoic acid (20 : 5n-3) 0·89 (0·43–1·84) 1·22 (0·61–2·43) 1·33 (0·65–2·71)
n-3-Docosapentaenoic acid (22 : 5n-3) 0·96 (0·46–1·99) 1·17 (0·54–2·54) 1·25 (0·57–2·72)
Docosahexaenoic acid (22 : 6n-3) 2·07 (1·00–4·29) 1·30 (0·60–2·82) 1·92 (0·90–4·10)
* Defined as answering ‘Yes’ to the question ‘Do you have nasal allergies, including hay fever?’
† Adjusted for age group (20–29, 30–39, 40–49, 50–59, $60 years), sex, education (low, middle, high), smoking status (never,
ex, current), BMI (continuous) and total energy intake (kcal/d, continuous).
‡ The first quartile was set as the reference category.
Table 4. Adjusted odds ratios and corresponding 95 % CI for the association between selected fatty acids in
serum phospholipids (%) and allergic sensitisation* (n 737)
Adjusted odds ratios (95 % CI)†
2nd quartile‡ 3rd quartile‡ 4th quartile‡
Fatty acid
Saturated
Palmitic acid (16 : 0) 0·64 (0·38–1·08) 1·11 (0·68–1·79) 0·75 (0·44–1·27)
Stearic acid (18 : 0) 0·92 (0·55–1·52) 0·96 (0·57–1·60) 0·76 (0·44–1·31)
Monounsaturated
Palmitoleic acid (16 : 1n-7) 1·21 (0·73–2·01) 1·25 (0·75–2·08) 1·29 (0·76–2·18)
Oleic acid (18 : 1n-9) 1·65 (0·97–2·83) 2·03 (1·20–3·43) 1·70 (0·98–2·92)
trans-18 : 1 0·98 (0·60–1·61) 1·11 (0·68–1·80) 0·67 (0·40–1·13)
n-6 Series polyunsaturated
Linoleic acid (18 : 2n-6) 1·05 (0·63–1·75) 1·29 (0·78–2·15) 0·99 (0·58–1·69)
g-Linolenic acid (18 : 3n-6) 1·03 (0·62–1·72) 1·65 (0·99–2·74) 1·27 (0·73–2·19)
Dihomo-g-linolenic acid (20 : 3n-6) 1·31 (0·80–2·12) 0·81 (0·48–1·36) 1·02 (0·61–1·72)
Arachidonic acid (20 : 4n-6) 0·99 (0·59–1·66) 1·19 (0·71–1·97) 1·14 (0·68–1·89)
Docosatetraenoic acid (22 : 4n-6) 0·85 (0·51–1·40) 0·99 (0·61–1·62) 0·87 (0·52–1·45)
n-6-Docosapentaenoic acid (22 : 5n-6) 1·36 (0·83–2·23) 0·92 (0·55–1·56) 1·10 (0·65–1·86)
n-3 Series polyunsaturated
a-Linolenic acid (18 : 3n-3) 0·90 (0·54–1·48) 1·10 (0·68–1·79) 1·01 (0·61–1·68)
Eicosapentaenoic acid (20 : 5n-3) 1·13 (0·68–1·88) 1·29 (0·78–2·15) 1·51 (0·90–2·55)
n-3-Docosapentaenoic acid (22 : 5n-3) 0·96 (0·57–1·63) 1·07 (0·61–1·87) 1·21 (0·68–2·12)
Docosahexaenoic acid (22 : 6n-3) 1·42 (0·86–2·33) 1·04 (0·62–1·76) 1·50 (0·89–2·52)
* Defined as at least one specific IgE $ 0·7 kU/l.
† Adjusted for age group (20–29, 30–39, 40–49, 50–59, $60 years), sex, education (low, middle, high), smoking status (never,
ex, current), BMI (continuous) and total energy intake (kcal/d, continuous).
‡ The first quartile was set as the reference category.
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sensitisation. Hay fever was self-reported, and individuals might
be sensitised against allergens other than the five we had
measured, which might have caused misclassification, but to us
this seems unlikely. Although sensitisation reflects the suscepti-
bility of an individual to develop allergic diseases, hay fever is
the clinical outcome of the disease. Arachidonic acid might be
an important factor in the clinical manifestation of allergic dis-
eases such as hay fever.
Woods et al. (2004) did not observe any association between
atopy, as assessed by a skin-prick test or several outcome vari-
ables for asthma, and arachidonic acid content in serum phospho-
lipids in adults. Interestingly, they observed a positive association
between asthma and dihomo-g-linolenic, the direct precursor of
arachidonic acid, but no association with atopy. The authors
applied linear regression models, whereas we applied logistic
regression models because the association between hay fever
and arachidonic acid was not linear in our study.
Two studies conducted on children did not find significantly
elevated arachidonic acid levels in serum or plasma phospholi-
pids, respectively, in atopic and healthy children (Leichsenring
et al. 1995; Yu & Björkstén, 1998). Leichsenring et al. (1995)
even found a significantly lower proportion of arachidonic acid
in the plasma cholesterol esters of children with atopic bronchial
asthma. However, only 45 (Yu & Björkstén, 1998) and 27 (Leich-
senring et al. 1995) participants were included in the two studies.
Analysing the dietary data of this study, Trak-Fellermeier et al.
(2004) did not find an association between arachidonic acid
intake and hay fever in adults. In a European Prospective Inves-
tigation into Cancer and Nutrition (EPIC) substudy conducted
in Germany, Nagel et al. (2003) observed a falling tendency
towards an adult onset of the clinical symptoms of hay fever
from the first to the fourth quartile of arachidonic acid intake.
Thus, published results on the association between hay fever
and arachidonic acid in serum phospholipids, as well as arachido-
nic acid intake, are not consistent.
In the present study, the arachidonic acid concentration in
serum phospholipids was 9·6 %, which was nearly half that of
linoleic acid, at 20·2 %. While less than 300 mg arachidonic
acid per day is consumed in the human diet, a typical Western
diet provides 10–15 g of linoleic acid per day (Calder & Miles,
2000). In general, the composition of fatty acids in serum phos-
pholipids shows a pattern different from that of other fat moieties
in the blood (triacylglycerols, cholesterol esters). Due to the meta-
bolic handling, serum phospholipids have recently been estab-
lished, and are widely used, as biomarkers of fatty acid intake.
However, it does not reflect fatty acid proportions as found in a
typical Western diet.
One might speculate that the low-point estimate in the first
quartile might be an indicator of metabolic protection. Individuals
with the lowest concentrations of arachidonic acid in their serum
phospholipids might have metabolic features that inhibit the syn-
thesis or enrichment of arachidonic acid in the serum phospholi-
pids. Another possible explanation is that arachidonic acid is a
marker of inflammation, although this seems unlikely to us,
because only 10 % of the population are affected by hay fever,
but the risk of this disease is high in the second to fourth quar-
tile, which applies 75 % of the population. Nevertheless, our find-
ings might be due to chance.
These results, showing a positive association between hay fever
and arachidonic acid in serum phospholipids, are in accordance
with the underlying hypothesis, because a higher availability of
arachidonic acid might promote the production of inflammatory
mediators that play an important role in allergic diseases. Therefore,
the relationship between arachidonic acid concentration in the
serum lipids and allergic diseases deserves further investigation.
In the present study, we did not find an association between the
linoleic acid concentration of serum phospholipids and allergic
diseases in adults, which is in accordance with the results of
Woods et al. (2004). Studies on the association between the diet-
ary intake of linoleic acid and adult-onset hay fever (Nagel et al.
2003) or atopic diseases in adults (Trak-Fellermeier et al. 2004)
also did not find a significant relationship.
Neither the precursors of arachidonic acid, g-linolenic acid and
dihomo-g-linolenic acid, nor the elongation and desaturation pro-
ducts adrenic acid and n-6 docosapentaenoic acid, showed any
association with hay fever, sensitisation or total IgE in serum in
the present study.
n-3 Fatty acids
In our study EPA and n-3 docosapentaenoic acid showed
no association with hay fever or allergic sensitisation, which is con-
sistent with the results of Woods et al. (2004) on atopy. Nagel et al.
(2003) did not find an association between the overall intake of n-3
PUFA and adult-onset hay fever, but these authors reported a nega-
tive association between EPA intake and hay fever. It is hypoth-
esised that a high intake of n-3 fatty acids, especially EPA, leads
to a partial replacement of arachidonic acid in the cell membranes
by EPA. This results in a suppressed production of arachidonic
acid-derived pro-inflammatory eicosanoids such as 4-series leuko-
trienes (Calder, 2003). Wakai et al. (2001) found a positive associ-
ation between the dietary intake of n-6 PUFA, but no association
between the dietary intake of n-3 PUFA, and symptoms of seasonal
allergic rhinoconjunctivitis in women.
Because fatty fish and fish oils are rich in EPA and docosahexae-
noic acid, numerous epidemiological and clinical studies have been
conducted on the association between fish intake or fish oil sup-
plementation and asthma. Clinical trials on fish-oil supplementation
for patients with asthma showed little evidence for a beneficial
effect of marine fatty acids on asthma (Woods et al. 2003). Epide-
miological studies on the association between asthma and fish con-
sumption show inconsistent results, and studies on the association
between hay fever and fish consumption are rare. A study conducted
on teenagers in Taiwan failed to find an association between fish
intake and allergic rhinitis (Huang et al. 2001). On the other hand,
a Norwegian study reported a negative association between the
introduction of fish into the diet before the age of 12 months and
allergic rhinitis at the age of 4 years (Nafstad et al. 2003). Because
sensitisation to allergens occurs early in life (Jones et al. 1996), fish
might have to be included in the maternal diet or be eaten at a very
early age to induce effects, a situation that is not common in most
other Western countries.
Another reason for the lack of association between EPA or doc-
osahexaenoic acid could be that the dietary intake of fish and fish
products was very low in the present study population. Fifty-four
per cent of the study population did not report any fish intake in
their dietary records. For the participants who ate fish, the mean
intake was 40 g/d and the median intake 32 g/d, and only 6 %
reported an intake of more than 100 g fish and fish products a
day. Therefore, the intake and consequently concentration of
EPA and docosahexaenoic acid in phospholipids might be too
low for any effect to be seen.
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We observed no association between a-linolenic acid concen-
tration in serum phospholipids and hay fever or allergic sensitis-
ation, which is consistent with the results of Woods et al. (2004)
and data on the dietary intake of a-linolenic acid (Nagel et al.
2003; Trak-Fellermeier et al. 2004).
Monounsaturated fatty acids
Two recently published studies reported a positive association
between the dietary intake of oleic acid and adult-onset hay
fever in adults (Nagel et al. 2003) and allergic sensitisation and
hay fever in females (Trak-Fellermeier et al. 2004). This is con-
sistent with the results of Heinrich et al. (2001), who observed a
positive association between the energy-adjusted intake of mono-
unsaturated fatty acids and the prevalence of allergic sensitisation
in Europe, and our findings on the association between allergic
sensitisation and oleic acid concentration in serum phospholipids.
Conversely, Woods et al. (2004) did not see any association
between allergic sensitisation, as assessed by a skin-prick test,
and oleic acid concentration in serum phospholipids. Nagel et al.
(2003) speculated that a high intake of oleic acid is concomitant
with a high intake of trans-fatty acids, because they appear in the
same foods.
In an ecological study, Weiland et al. (1999) observed a posi-
tive association between the dietary intake of trans fatty acids and
the prevalence of asthma, allergic rhinoconjunctivitis and atopic
eczema in children aged 13–14 years in fourteen European
countries. In the present study on adults, we have not found
any association between the intake of monounsaturated trans-
18 : 1 and hay fever or allergic sensitisation. However, we could
not separate both isomers of trans-18 : 1, elaidic acid (9trans-
18 : 1), which is the predominant trans isomer in partially hydro-
genated vegetable oil, and vaccenic acid (11trans-18 : 1), which is
predominant in ruminant fat.
In Germany, trans fatty acid intake is low compared with that
of other Western countries, and 79 % of trans fatty acids in 1995/
96 were derived from milk and ruminant fat, which is the highest
proportion in Western Europe (Hulshof et al. 1999). In the Nor-
wegian diet only 28 % (Hulshof et al. 1999), and in the American
diet only 5 %, of trans fatty acids are derived from animal fat, the
remaining 95 % coming from partially hydrogenated vegetable
oils (Semma, 2002). In their ecological study, Weiland et al.
(1999) observed a stronger positive association between asthma,
allergic rhinoconjunctivitis and atopic eczema in children and
trans fatty acid intake when they restricted their analysis to
foods that contained predominantly partially hydrogenated oils.
Several studies on coronary heart disease have also found a posi-
tive association with the dietary intake of trans fatty acids from
partially hydrogenated vegetable oils, but not with trans fatty
acids occurring in milk and ruminant fat (Meijer et al. 2001).
One might speculate that only elaidic acid has an influence on
atopic diseases, although there is no clear biological explanation
for different effects of elaidic and vaccenic acid (Meijer et al.
2001). Elaidic acid is contained in fast food and baked products
such as cake and biscuits, so the intake of this trans fatty acid
might also be an indicator of a certain lifestyle.
Fatty acids and total immunoglobulin E
To assess the association between fatty acids and total IgE in
serum, the eight fatty acids oleic acid (18 : 1n-9), linoleic acid
(18 : 2n-6), dihomo-g-linolenic acid (20 : 3n-6), arachidonic acid
(20 : 4n-6), docosatetraenoic acid (22 : 4n-6), a-linolenic acid
(18 : 3n-3), EPA (20 : 5n-3) and trans-18 : 1 were considered.
None showed any influence on the concentration of total IgE in
serum. This is consistent with the interim results of an Australian
study on n-3 fatty acid supplementation in infants. Mihrshahi et al.
(2003) found no difference in the level of total IgE in serum
between infants who received n-3 fatty acid supplementation in
the first 18 months of life and those who did not. Yu & Björkstén
(1998) reported lower concentrations of EPA in the serum phos-
pholipids of children with a total IgE above the median and higher
concentrations of 20 : 2n-6. However, the biological function of
this minor fatty acid is unknown (Yu & Björkstén, 1999). To
our knowledge, no other studies have yet been published on the
association between fatty acids and total IgE.
We measured fatty acid concentrations in serum phospholipids
as a biomarker of recent fatty acid intake (Ma et al. 1995; Arab,
2003) and of metabolism, because fatty acid concentrations in the
serum phospholipids better reflect fatty acid availability in the
body. It has been nicely shown in intervention studies administer-
ing n-3 PUFA that its content increased in plasma phospholipids
in a time- and dose-dependent manner and was followed by an
enrichment in the white and red blood cells (von Schacky et al.
1985; Gibney & Hunter, 1993; Kew et al. 2004). Although less
distinct, this is also observable after high dosages of n-6 polyun-
saturated and monounsaturated fatty acids.
We do not know the extent to which ingested fatty acids get
metabolised in the body. There are some factors that influence
the measured fatty acid biomarker level, for example genetic
polymorphisms of elongase and desaturase enzymes, and nutri-
tional status (Arab, 2003).
It might be possible that the long-term storage of serum
samples has led to the oxidation of the long-chain PUFA. To
the present authors, however, it seems unlikely that predomi-
nantly n-3 or n-6 PUFA were damaged. Zeleniuch-Jacquotte
et al. (2000) reported that the storage of serum samples for up
to 12 years at 2808C protected the fatty acids in phospholipids
against oxidation very well.
We used self-reported hay fever as an outcome variable, but
this was not confirmed by a physician. Because allergic sensitis-
ation, measured by the analysis of specific IgE in serum, showed
similar associations with most fatty acids in serum phospholipids,
we do not think that the self-reported diagnosis caused a strong
bias.
The results of the present study should be interpreted with cau-
tion because of the cross-sectional nature of our study design,
which does not establish a relationship between cause and
effect. Furthermore, the power of our study is questionable and
could be criticised. We conducted a secondary analysis with a
relatively high number of participants, but by categorising the
fatty acid values into quartiles, information is lost. Owing to
the inconsistent results on the association between fatty acids
and allergic diseases in studies conducted so far, we think this
topic warrants further investigation.
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